Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KLHL30 antisense RNA 1 (KLHL30-AS1) is a human long non-coding RNA gene (lncRNA), sometimes referred to by its previous symbol C2orf19. It is categorized as a non-coding RNA and has not been functionally characterized in scientific literature to date. No validated roles in disease, drug interactions, or molecular pathways are established for KLHL30-AS1, and it is not currently considered a therapeutic target[3][5][6]. The gene is annotated in humans (HGNC:31018, NCBI Gene:394261, Ensembl:ENSG00000279484), and lacks known association with protein function or established involvement in molecular mechanisms or clinical conditions[3]. Since it is a non-coding RNA with no established function, the current classification is limited to "Long non-coding RNA". If further context is required for structured data or novel findings emerge, future database updates or experimental studies may clarify its biological relevance or potential therapeutic implications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KLHL30 antisense RNA 1 (KLHL30-AS1).